TY - JOUR
T1 - Temporal and spatial regulation of epsin abundance and VEGFR3 signaling are required for lymphatic valve formation and function
AU - Liu, Xiaolei
AU - Pasula, Satish
AU - Song, Hoogeun
AU - Tessneer, Kandice L.
AU - Dong, Yunzhou
AU - Hahn, Scott
AU - Yago, Tadayuki
AU - Brophy, Megan L.
AU - Chang, Baojun
AU - Cai, Xiaofeng
AU - Wu, Hao
AU - McManus, John
AU - Ichise, Hirotake
AU - Georgescu, Constantin
AU - Wren, Jonathan D.
AU - Griffin, Courtney
AU - Xia, Lijun
AU - Srinivasan, R. Sathish
AU - Chen, Hong
PY - 2014/10/14
Y1 - 2014/10/14
N2 - Lymphatic valves prevent the backflow of the lymph fluid and ensure proper lymphatic drainage throughout the body. Local accumulation of lymphatic fluid in tissues, a condition called lymphedema, is common in individuals with malformed lymphatic valves. The vascular endothelial growth factor receptor 3 (VEGFR3) is required for the development of lymphatic vascular system. The abundance of VEGFR3 in collecting lymphatic trunks is high before valve formation and, except at valve regions, decreases after valve formation. We found that in mesenteric lymphatics, the abundance of epsin 1 and 2, which are ubiquitin-binding adaptor proteins involved in endocytosis, was low at early stages of development. After lymphatic valve formation, the initiation of steady shear flow was associated with an increase in the abundance of epsin 1 and 2 in collecting lymphatic trunks, but not in valve regions. Epsin 1 and 2 bound to VEGFR3 and mediated the internalization and degradation of VEGFR3, resulting in termination of VEGFR3 signaling. Mice with lymphatic endothelial cell-specific deficiency of epsin 1 and 2 had dilated lymphatic capillaries, abnormally high VEGFR3 abundance in collecting lymphatics, immature lymphatic valves, and defective lymph drainage. Deletion of a single Vegfr3 allele or pharmacological suppression of VEGFR3 signaling restored normal lymphatic valve development and lymph drainage in epsin-deficient mice. Our findings establish a critical role for epsins in the temporal and spatial regulation of VEGFR3 abundance and signaling in collecting lymphatic trunks during lymphatic valve formation.
AB - Lymphatic valves prevent the backflow of the lymph fluid and ensure proper lymphatic drainage throughout the body. Local accumulation of lymphatic fluid in tissues, a condition called lymphedema, is common in individuals with malformed lymphatic valves. The vascular endothelial growth factor receptor 3 (VEGFR3) is required for the development of lymphatic vascular system. The abundance of VEGFR3 in collecting lymphatic trunks is high before valve formation and, except at valve regions, decreases after valve formation. We found that in mesenteric lymphatics, the abundance of epsin 1 and 2, which are ubiquitin-binding adaptor proteins involved in endocytosis, was low at early stages of development. After lymphatic valve formation, the initiation of steady shear flow was associated with an increase in the abundance of epsin 1 and 2 in collecting lymphatic trunks, but not in valve regions. Epsin 1 and 2 bound to VEGFR3 and mediated the internalization and degradation of VEGFR3, resulting in termination of VEGFR3 signaling. Mice with lymphatic endothelial cell-specific deficiency of epsin 1 and 2 had dilated lymphatic capillaries, abnormally high VEGFR3 abundance in collecting lymphatics, immature lymphatic valves, and defective lymph drainage. Deletion of a single Vegfr3 allele or pharmacological suppression of VEGFR3 signaling restored normal lymphatic valve development and lymph drainage in epsin-deficient mice. Our findings establish a critical role for epsins in the temporal and spatial regulation of VEGFR3 abundance and signaling in collecting lymphatic trunks during lymphatic valve formation.
UR - http://www.scopus.com/inward/record.url?scp=84908399275&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908399275&partnerID=8YFLogxK
U2 - 10.1126/scisignal.2005413
DO - 10.1126/scisignal.2005413
M3 - Article
C2 - 25314967
AN - SCOPUS:84908399275
SN - 1945-0877
VL - 7
SP - ra97
JO - Science Signaling
JF - Science Signaling
IS - 347
ER -